Lantern Pharma Inc. Common Stock (LTRN)
PHARMACEUTICAL PREPARATIONS
Lantern Pharma Inc. Common Stock (LTRN) is listed on Nasdaq, where it has traded since June 11, 2020.
- Listed On
- Nasdaq
- Listed Since
- June 11, 2020
- Employees
- 16
- Market Cap
- $14M
About Lantern Pharma Inc. Common Stock
Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 37 institutions reported holding LTRN, with 2.9 million shares worth $12.0 million in aggregate. The largest reported holder was Empery Asset Management, with 842,669 shares worth $3.5 million. Of the 5 largest holders listed below, 1 opened a new position in LTRN, 3 added shares and 1 reduced its position during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| Empery Asset Management | 842,669 | $4M | New position |
| CM Management | 500,000 | $2M | Added 100% |
| Vanguard | 477,423 | $2M | Added 24.32% |
| Renaissance Technologies | 291,039 | $1M | Added 150.9% |
| Bios Capital Management | 249,397 | $1M | Reduced 71.15% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is LTRN?
Lantern Pharma Inc. Common Stock (LTRN) is listed on Nasdaq, where it has traded since June 11, 2020.
Who are the largest institutional holders of LTRN?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of LTRN were Empery Asset Management, CM Management and Vanguard.
How many institutions own LTRN?
37 institutions reported a position in LTRN for the quarter ended June 30, 2026, worth $12.0 million in total.
Did institutions buy or sell LTRN last quarter?
Of the 5 largest reported holders, 1 opened a new position in LTRN, 3 added shares and 1 reduced its position during the quarter. Every reported holder and its change is on the SentiSense ownership page for LTRN.
Every reported institutional holder, plus insider and congressional trades in LTRN, on SentiSense.